Peter J. Wedlund

1.8k total citations
39 papers, 1.4k citations indexed

About

Peter J. Wedlund is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Peter J. Wedlund has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 9 papers in Pediatrics, Perinatology and Child Health and 8 papers in Molecular Biology. Recurrent topics in Peter J. Wedlund's work include Pharmacogenetics and Drug Metabolism (23 papers), Drug Transport and Resistance Mechanisms (7 papers) and Epilepsy research and treatment (5 papers). Peter J. Wedlund is often cited by papers focused on Pharmacogenetics and Drug Metabolism (23 papers), Drug Transport and Resistance Mechanisms (7 papers) and Epilepsy research and treatment (5 papers). Peter J. Wedlund collaborates with scholars based in United States, Iraq and China. Peter J. Wedlund's co-authors include José de León, Walter Koch, Margaret T. Susce, Thea Rogers, Robert Guttendorf, Fengxiang Yan, Thomas B. Ryder, Wei Wei Liu, Robert A. Blouin and Shuqing Chen and has published in prestigious journals such as Methods in enzymology on CD-ROM/Methods in enzymology, Journal of Neurochemistry and Clinical Chemistry.

In The Last Decade

Peter J. Wedlund

39 papers receiving 1.3k citations

Peers

Peter J. Wedlund

PHARM

PMH

PPCH

ONCOL

Per Dalén Sweden

J. Brockmöller Germany

I Roots Germany

Y. W. Francis Lam United States

Julio Benítez Spain

Juan Antonio Carrillo Spain

J. Benítez Spain

John T. Callaghan United States

L. P. Balant Switzerland

Werner Steimer Germany

Per Dalén Sweden

Peter J. Wedlund

656 ×0.9

PHARM

293 ×0.7

PMH

254 ×0.9

PPCH

177 ×0.7

233 ×1.0

ONCOL

Citations per year, relative to Peter J. Wedlund Peter J. Wedlund (= 1×) peers Per Dalén

Countries citing papers authored by Peter J. Wedlund

Since Specialization

Citations

This map shows the geographic impact of Peter J. Wedlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Wedlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Wedlund more than expected).

Fields of papers citing papers by Peter J. Wedlund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Wedlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Wedlund. The network helps show where Peter J. Wedlund may publish in the future.

Co-authorship network of co-authors of Peter J. Wedlund

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Wedlund. A scholar is included among the top collaborators of Peter J. Wedlund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Wedlund. Peter J. Wedlund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fernander, Anita, et al.. (2008). Smoking Risk and the Likelihood of Quitting among African-American Female Light and Heavy Smokers. Journal of the National Medical Association. 100(10). 1199–1206. 11 indexed citations

Zhu, Jun, Michael T. Bardo, Thomas A. Green, Peter J. Wedlund, & Linda P. Dwoskin. (2007). Nicotine increases dopamine clearance in medial prefrontal cortex in rats raised in an enriched environment. Journal of Neurochemistry. 103(6). 2575–2588. 18 indexed citations

Crooks, Peter A., et al.. (2006). Nornicotine inhibition of dopamine transporter function in striatum via nicotinic receptor activation. Synapse. 61(3). 157–165. 12 indexed citations

León, José de, et al.. (2005). Polymorphic Variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and Dopamine D2 and D3 Receptors and Their Association With Tardive Dyskinesia in Severe Mental Illness. Journal of Clinical Psychopharmacology. 25(5). 448–456. 81 indexed citations

León, José de, et al.. (2005). The CYP2D6 Poor Metabolizer Phenotype May Be Associated With Risperidone Adverse Drug Reactions and Discontinuation. The Journal of Clinical Psychiatry. 66(1). 15–27. 230 indexed citations

León, José de, Francisco J. Díaz, Peter J. Wedlund, et al.. (2004). Haloperidol Half-life After Chronic Dosing. Journal of Clinical Psychopharmacology. 24(6). 656–660. 27 indexed citations

Yan, Fengxiang, M. Chris Langub, Carlton A. Hornung, et al.. (2003). CYP2D6, GST‐M1 and GST‐T1 enzymes: expression in parathyroid gland and association with the parathyroid hormone concentration during early renal replacement therapy. British Journal of Clinical Pharmacology. 56(1). 68–77. 8 indexed citations

Wedlund, Peter J.. (2001). Practical considerations for pharmacogenetic testing.. PubMed. 33(9). 16–21, 23; quiz 24. 2 indexed citations

Wedlund, Peter J.. (2000). The CYP2C19 Enzyme Polymorphism. Pharmacology. 61(3). 174–183. 134 indexed citations

10.

Yan, Fengxiang, José de León, John W. Barnhill, et al.. (2000). Extension of a Pilot Study: Impact From the Cytochrome P450 2D6 Polymorphism on Outcome and Costs Associated With Severe Mental Illness. Journal of Clinical Psychopharmacology. 20(2). 246–251. 164 indexed citations

11.

Wedlund, Peter J. & G. Wilkinson. (1996). [11] In vivo and in vitro measurement of CYP2C19 activity. Methods in enzymology on CD-ROM/Methods in enzymology. 272. 105–114. 12 indexed citations

12.

Jewell, Ann, Peter J. Wedlund, & Linda P. Dwoskin. (1993). Strain differences in rat brain and liver σ binding: lack of cytochrome P450-2D1 involvement. European Journal of Pharmacology. 243(3). 249–254. 9 indexed citations

13.

Colangelo, Philip M., Robert A. Blouin, Joseph E. Steinmetz, et al.. (1992). Age and propranolol stereoselective disposition in humans. Clinical Pharmacology & Therapeutics. 51(5). 489–494. 23 indexed citations

14.

Guttendorf, Robert & Peter J. Wedlund. (1992). Genetic Aspects of Drug Disposition and Therapeutics. The Journal of Clinical Pharmacology. 32(2). 107–117. 22 indexed citations

15.

Wedlund, Peter J., et al.. (1992). Interaction of valproic acid and some analogues with microsomal epoxide hydrolase. Biochemical Pharmacology. 43(4). 775–783. 11 indexed citations

16.

Zhang, Ying, et al.. (1992). Dextromethorphan: Enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome P4502D6. Clinical Pharmacology & Therapeutics. 51(6). 647–655. 73 indexed citations

17.

Wedlund, Peter J., et al.. (1990). A Pharmacogenetic Screening Experiment Demonstrating Principles of Genetic Constitution on Drug Metabolism. American Journal of Pharmaceutical Education. 54(3). 243–249. 2 indexed citations

18.

Guttendorf, Robert, H.B. Kostenbauder, & Peter J. Wedlund. (1989). Quantification of propranolol enantiomers in small blood samples from rats by reversed-phase high-performance liquid chromatography after chiral derivatization. Journal of Chromatography B Biomedical Sciences and Applications. 489(2). 333–343. 21 indexed citations

19.

Akrawi, Sabah H. & Peter J. Wedlund. (1989). Mephenytoin stereoselective elimination in the rat: II. Comparison of mephenytoin stereoselective clearance during chronic intravenous and hepatic portal vein administration. European Journal of Drug Metabolism and Pharmacokinetics. 14(4). 269–278. 6 indexed citations

20.

Guttendorf, Robert, Peter J. Wedlund, J. W. Blake, & Shih‐Lin Chang. (1988). Simplified Phenotyping with Dextromethorphan by Thin-Layer Chromatography. Therapeutic Drug Monitoring. 10(4). 490–498. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact